Cancer immunotherapy‐targeted glypican‐3 or neoantigens

Immune checkpoint inhibitors have ushered in a new era in cancer therapy, although other therapies or combinations thereof are still needed for many patients for whom these drugs are ineffective. In this light, we have identified glypican‐3 an HLA‐24, HLA‐A2 restriction peptide with extreme cancer s...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Sci
Main Authors: Shimizu, Yasuhiro, Suzuki, Toshihiro, Yoshikawa, Toshiaki, Tsuchiya, Nobuhiro, Sawada, Yu, Endo, Itaru, Nakatsura, Tetsuya
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Thematic Section: Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834776/
https://ncbi.nlm.nih.gov/pubmed/29285841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13485
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items